FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin
By admin at 4 February, 2010, 6:33 am
ROCKVILLE, Md., Feb.
Go here to see the original:
FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin
Related posts:
- FDA warns Allergan on Aczone promotion Washington ?An advertisement for Aczone (Allergan), a gel used to...
- Sanofi strikes acne-vaccine R&D deal Sanofi Pasteur, the vaccines division of Paris-based drug firm Sanofi,...
- Reply to letter by Priori et al commenting on whether Behçet’s syndrome patients with acne and arthritis comprise a true subset No abstract. (Source: Arthritis and Rheumatism) MedWorm Message: Get the...
- Cure for acne- Benzaclin The medicine Benzaclin can be used taken as a treatment...
- BenzaClin-solution for the stubborn acne BenzaClin has been an active medication for the treatment of...
Categories :
Acne News

No comments yet.